Hire Now
Message Michael
Languages
English
French
Portuguese
Spanish
Usually responds
Within a few minutes
See how it works
Book Michael with Paydesk
Make your booking securely through paydesk for these benefits:
1
Preferred Booking Channel
Michael is more likely to commit to assignments booked through paydesk, as it is a trusted platform that validates the seriousness and legitimacy of each engagement.2
Insured Bookings for Peace of Mind
We provide basic insurance coverage with each booking on paydesk, giving both you and the media professional confidence and protection while they work for you.3
Effortless Online Payment
Paydesk offers a payment protection system to ensure payments are only finalized when you are satisfied with the job completion. Freelancers trusts our process that guarantees their efforts are rewarded upon successful delivery of servicesStill have questions?
Check FAQAbout Michael
Michael Susin is a journalist based in Gdańsk, Poland. Masters degree in Multimedia Journalism at UPV (Basque Country), Bachelor degree in Journalism at Universidade de Caxias do Sul (Brazil) and exchange program studies in Social Communication at Deustuko Unibertsatea - Basque Country. Expierence in multimedia content: production, script, storytelling, news and edition. Subjects of interest: Human Rights, Politics, International, War&Peace.
Portfolio
Haleon to Cut 435 Jobs, Shut U.K. Production Site
Haleon will shut its toothpaste and mouthwash production site in the U.K. by 2026, resulting in 435 job cuts. Toothpaste production will move to Slovakia, and mouthwash production will be transferred to a third party. Despite the closure, Haleon is investing over 130 million pounds in an oral health research and development facility in Weybridge, maintaining a substantial presence in the U.K. Shares rose by 2% following the announcement.
Haleon to Cut 435 Jobs, Shut U.K. Production Site
Haleon will shut its toothpaste and mouthwash production site in the U.K. by 2026, resulting in 435 job cuts. The toothpaste production will be relocated to Slovakia, and mouthwash production will be transferred to an undisclosed third party. Despite the closure, Haleon is investing over 130 million pounds in an oral health research and development facility in Weybridge, maintaining a significant presence in the U.K. Shares rose by 2% following the announcement.
Haleon to Cut 435 Jobs, Shut U.K. Production Site
Haleon will shut its toothpaste and mouthwash production site in the U.K. by 2026, resulting in 435 job cuts. The toothpaste production will be relocated to Slovakia, and mouthwash production will be transferred to an undisclosed third party. Despite the closure, Haleon is investing over 130 million pounds in an oral health research and development facility in Weybridge, maintaining a significant presence in the U.K. Shares rose by 2% following the announcement.
Aker Solutions Wins Contract to Upgrade Equinor Refinery in Norway
Aker Solutions has secured a significant contract from Equinor to upgrade the wastewater treatment plant at the Mongstad refinery in Norway. The project, valued between 2.5 billion and 4.0 billion Norwegian kroner, aims to reduce the environmental impact of the refinery and is expected to be completed by the fourth quarter of 2026.
Unilever Boosted by Power Brands as Consumers Trade Back Up
Unilever, the owner of Dove soap and other consumer brands like Cif and Domestos, reported better-than-expected turnover for the first quarter, driven by higher volumes and its power brands. The Anglo-Dutch retailer maintains its full-year guidance, expecting sales growth of 3% to 5% and a modest improvement in operating margin on an underlying basis.
Reckitt Benckiser Shares Plunge After Infant-Formula Verdict
Reckitt Benckiser's stock experienced its worst one-day percentage fall, dropping 17% to GBP43.52, after an Illinois jury found its Mead Johnson unit liable in a case involving its infant-formula Enfamil. The jury ordered Mead Johnson to pay $60 million in compensation for the death of a premature baby diagnosed with necrotizing enterocolitis after being fed Enfamil. Reckitt Benckiser, which also owns brands like Dettol and Durex, plans to challenge the verdict, stating that the science does not support the allegations.
Reckitt Benckiser Sheds Nearly $7 Billion in Market Value After Infant-Formula Verdict — Update
Reckitt Benckiser experienced a nearly $7 billion drop in market value after an Illinois jury ruled against its infant-formula unit, Mead Johnson, in a case involving the death of a premature baby fed Enfamil. The company's shares fell by almost 15%, and it plans to challenge the verdict, asserting that its products do not cause necrotizing enterocolitis. Market analysts suggest the share price drop may indicate investor concerns about future implications.
JD.com Walks Away From Currys's Takeover Talks — Update
JD.com has decided not to make a takeover offer for U.K. electronics retailer Currys, following a similar withdrawal by Elliott Advisors (UK). This news caused Currys's shares to drop over 10% before recovering slightly. Currys's board had previously rejected two offers from Elliott Advisors, considering them to undervalue the company. Elliott's last proposal on February 27 was a cash offer of 67 pence per share, totaling approximately 759.4 million pounds.
Reckitt Benckiser Sheds Nearly $7 Billion in Market Value After Infant-Formula Verdict -- Update
Reckitt Benckiser's market value plummeted by nearly $7 billion following an Illinois jury's verdict against its Enfamil infant formula, resulting in a $60 million compensation order. The company, which also owns brands like Dettol and Durex, strongly disagrees with the decision and plans to challenge it, asserting that their products do not cause necrotizing enterocolitis. The significant share drop suggests investor concerns about potential future impacts.
JD.com Walks Away From Currys Takeover Talks
JD.com, a Beijing-based marketplace, announced it will not make a takeover offer for Currys, ending a bid war shortly after Elliott Advisors (UK) also withdrew. JD.com did not provide further details on its decision. Earlier, Elliott Advisors had stated that Currys rejected multiple negotiation attempts.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium
doloremque laudantium,
totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur?
doloremque laudantium,
totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur?
Want to see more portfolio samples?
Sign up to paydesk, it’s free!
Log In
Sign Up
×
Michael's
confirmed information
✓
Phone number
Verified Aug 2018
✓
Joined
Aug 2018